EIP Pharma

About:

EIP Pharma is a clinical stage therapeutics company developing drugs to treat neurodegenerative diseases.

Website: http://www.eippharma.com

Twitter/X: eip_pharma

Top Investors: Access Industries, National Institute on Aging

Description:

EIP Pharma is a clinical stage therapeutics company that focuses on the development and commercialization of drug treatments for neurodegenerative diseases, with a particular emphasis on the early stages of the neurodegenerative process. The company's drug promotes function recovery in patients suffering from acute neurologic injury.

Total Funding Amount:

$59.6M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2014-01-01

Contact Email:

jalam(AT)eippharma.com

Founders:

John Alam, Sylvie Grégoire

Number of Employees:

1-10

Last Funding Date:

2023-01-18

IPO Status:

Private

Industries:

© 2025 bioDAO.ai